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Abstract
Aim: To explore how the patient is constructed and socially positioned in discourses 
of web-based pathways information available to people with cancer in Norway.
Design: Mixed qualitative and quantitative design, using Corpus-Assisted Critical 
Discourse Analysis.
Methods: The study, conducted in January 2020, examined the language of one 
general and six specific web-based cancer pathways information brochures. The ap-
proach combines analysis of word frequencies and concordance lines using corpus 
analysis software to identify the ‘linguistic fingerprint’ or ‘aboutness’ of the text prior 
to further qualitative critical discourse analysis.
Results: The analysis identified three core discourses which constructed the patient 
differently: (a) a participating active person, in a brief, inclusive discourse; (b) a passive 
person lacking knowledge or perception of their situation in dominant, medical and in-
terprofessional expert discourse; and (c) reduced to a disease and a code in the pathways 
discourse.
Conclusion: This study offers insight into the construction of patients in online clinical 
pathways information for cancer treatment. The analysis revealed how governance 
systems such as New Public Management and its demands on efficiency and produc-
tivity influence the cancer pathways. The World Health Organization has promoted a 
person-centred approach, emphasizing the importance of participation and a partner-
ship of equals. A person-centred approach to care was not evident in the discourse 
of the online documents. The dominant ideology of these pathways was paternalistic 
with patients constructed as passive persons who get standardized treatment.
Impact: This study gives new insight that can be valuable for nurses, other healthcare pro-
fessionals and the government. The lack of a person-centred focus in the cancer pathway 
information could have a negative impact on the patient's health outcomes by promoting 
a culture of inattention to the patients' needs and wishes among practitioners. The results 
may provide a stimulus for discussion about the role of patients in cancer treatment.
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1  | INTRODUC TION
The new cancer strategy in Norway, Living with Cancer (Ministry of 
Health & Care Services, 2018), is a continuation and update of the 
Government's earlier cancer strategy and sets out its ambition for a 
service where patients participate more, have an influence on their 
own treatment and get help to manage their illness and everyday life. 
This strategy focuses on the question of what is important for the 
patient and their needs.
In recent years, standardized cancer pathways have been in-
troduced internationally (Probst, Hussain, & Andersen, 2012). 
They were implemented in Norway in 2014 and last updated in 
2016 (Health Directorate, 2014). The goal is to contribute to a 
quick investigation and start of treatment without unnecessary 
waiting time (Helse.norge.no, 2020; Jensen et al., 2015). These 
pathways are supposed to achieve the best outcomes for people 
with cancer.
Although Scandinavian countries share a health care model 
with the primary goal of equal access to welfare, changes to gov-
ernance systems such as New Public Management (NPM) are 
placing ever-increasing demands on efficiency and productivity, 
raising questions and ethical dilemmas about patient social posi-
tions and agency. This kind of governance appears to undermine 
an emphasis in public documents about transferring more power 
to individual patients that has developed since the adoption of the 
Universal Declaration of Human Rights by the United Nations in 
1948. However, paternalistic ideology, where patients are assumed 
to comply and play minimal and passive roles, has dominated health 
care (Beauchamp & Childress, 2009; Collins, Britten, Ruusuvuori, & 
Thompson, 2007).
Indeed, Dahlborg Lyckhage, Pennbrant, and Boman (2017), 
Lassen, Ottesen, and Strunck (2018) and Aasen and Dahl (2019) 
identify ideological struggles in legal discourse across Scandinavian 
countries as national governance systems continue to exert hege-
monic power by strongly influencing patient choice and autonomy. 
This mixed messaging about patient participation and autonomy 
in the face of NPM is evident in Norway. On the one hand, recent 
public documents underline the rights of patients to participate, 
influence and make personal choices in health care (Ministry of 
Health & Care Services, 1999a, 2015), as set down in Norwegian 
law (Ministry of Health & Care Services, 1999a, 1999b) which ob-
ligates acceptable levels of health assistance to patients and their 
family members. Yet, on the other hand, Norway's renamed and 
revised Patients' and Service Users' Rights Act (Ministry of Health 
& Care Services, 1999b) and the published official commentary 
accompanying this legislation from the Norwegian Ministry of 
Health and Care Service, retains a dominant paternalistic dis-
course (Aasen & Dahl, 2019). It is a discourse that validates the 
power of medicine, the healthcare system and health personnel 
over the needs, rights, participation and autonomy of the patient 
(Aasen & Dahl, 2019). This study analyses the discourses in the 
Norwegian cancer pathways and investigates how the patients are 
constructed.
1.1 | Background
The World Health Organization has promoted a person-centred ap-
proach, with a global goal of humanizing health care by ensuring that 
it is rooted in universal principles of human rights:
The overall vision for people-centered health care is 
one in which individuals, families and communities are 
served by and are able to participate in trusted health 
systems that respond to their needs in humane and 
holistic ways… (McCormack et al., 2015)
Aasen, Kvangarsnes, Wold, and Heggen (2012) described the con-
cept of patient participation as involving the relationship between pa-
tients and the health-care team, who engage in a process of power 
exchange. Participation ‘does not necessarily require shared deci-
sion-making but rather a dialogue with shared information and knowl-
edge and mutual engagement in intellectual and/or physical activities 
influenced by the context’.
Person-centred practice is now almost in the nursing and 
healthcare discourse and as a global movement (McCormack et al., 
2015). The person-centred nursing framework of McCormack and 
McCance (2010, 2018) has influenced practice and policy develop-
ment. As Richards, Coulter, and Wicks (2015) (p. 3) argue, the chal-
lenge remains one of overcoming ‘system’ inertia and paternalism 
and that a significant part of this change is the need to shift the dis-
course away from person-centred ‘care’ and to a unified discourse of 
person-centred ‘cultures’.
The implementation of care pathways has been concerned with 
improving the healthcare system, reducing unnecessary practice 
variation, enhancing coordination and continuity and achieving 
better clinical outcomes (Faber, Grande, Wollersheim, Hermens, & 
Wlwyn, 2014). The length of hospital stay has decreased and, as a 
result, the costs have reduced, with fewer in-hospital complications 
observed (Rotter et al., 2010). However, this standardization of orga-
nizational procedures and evidenced-based care also has an evident 
drawback. Care pathways have mainly been developed by health-
care specialists and have been disease-based (Røstad, Garåsen, 
Steinsbekk, Sletvold, & Grimsmo, 2013).
Studies connected to cancer pathways point to the importance 
of patient participation and communication. Active patient partici-
pation in formulating the treatment plan alongside clinician's support 
and encouragement were fields that had a positive health out-
come to patients (Ishikawa & Yano, 2008; Street, Makoul, Arora, & 
Epstein, 2009). Over recent decades we have perhaps assumed that 
there has been a shift from paternalism to patient participation. We 
may consider that patient autonomy is respected and information 
and decisions are shared between physician and patient (Ishikawa & 
Yano, 2008). However, a systematic review of end-of-life care path-
ways for improving outcomes in caring for the dying (Chan, Webster, 
& Bowers, 2016), maintained that there are substantial concerns 
about safety and quality of care associated with the pathway im-
plementation and limited available evidence concerning the clinical, 
     |  3AASEN Et Al.
physical, psychological or emotional effectiveness of end-of-life care 
pathways.
There are now 28 pathways for cancer in Norway, providing pa-
tients with greater predictability for assessment and an active role 
in timely treatment, not least through online resources. However, 
there has been no research into whether this online material sup-
ports or advances participation.
2  | THE STUDY
2.1 | Aim
The aim of this study is to explore how the patient is constructed and 
socially positioned in the discourses of web-based pathways available 
to people with cancer. The following research question was addressed:
How are the patients constructed in the cancer path-
ways in Norway?
2.2 | Design
A mixed qualitative and quantitative design was employed, using 
Corpus-Assisted Critical Discourse Analysis. This study uses a 
Corpus-Assisted Critical Discourse Analysis to examine the lan-
guage of web-based cancer care pathways information in Norway. 
This is a ‘tried and tested’ mixed methods approach (Crawford, 
Gilbert, Gilbert, Gale, & Harvey, 2013) which has become estab-
lished over the last 15 years (see Adolphs, Brown, Carter, Crawford, 
& Sahota, 2004; Atanasova, Koteyko, Brown, & Crawford, 2017; 
Crawford, Brown, & Harvey, 2014). Typically, the approach com-
bines analysis of word frequencies and concordance lines using 
corpus analysis software to identify the ‘linguistic fingerprint’ or 
‘aboutness’ of the text (Scott, 2006) prior to further qualitative dis-
course analysis.
In this study, we use AntConc 3.2.1. software (Anthony, 2010) 
to capture the ‘aboutness’ of the language used in the care path-
ways documents to underpin subsequent qualitative discourse an-
alytic work (Louw, 1993; Sinclair, 1991). This subsequent phase will 
comprise a constructionist discourse analysis (Tuominen, Talja, & 
Savolainen, 2002), which draws on the tradition of Critical Discourse 
Analysis (Baker, 2012; Fairclough, 2003; Lin, 2014). We can think of 
the quantitative component as a ‘baseline’ to support the claims of the 
subsequent analysis (Crawford et al., 2013) whereby we examine the 
language as a social and political practice that advances a particular 
version or construction of the reality of care pathways.
A discourse represents a particular part of the world from a 
specific perspective (Fairclough, 2003). Discourses can possess 
different types of order; notably one aspect of this order is domi-
nance. Critical discourse analysis seeks to uncover how power and 
dominance are manifested through language (Fairclough, 2001). 
Fairclough (2001) suggests that ideology, hegemony and power are 
three central concepts in discourses. He defines ideology as a set 
of beliefs and attitudes shared by members of a group. The most 
powerful or hegemonic discourse in any field emerges from the 
social struggle for dominance as ideological meanings are estab-
lished. Fairclough (1992) also made a distinction between power in 
a discourse and power behind a discourse. The power behind the 
discourse is the hidden effect of discourse, an effect of power. It 
influences a person's identity, relationships, knowledge and beliefs 
(Fairclough, 1992, 2001, 2003).
2.3 | Sample and data collection
The study examines web-based cancer care pathways information 
to patients and relatives. The Norwegian Directorate of eHealth 
(NDE), a subordinate institution of Norway's Ministry of Health and 
Care Services is the collective author of the texts analysed in this 
study. Patients and relatives can access this information through 
the link Helsenorge.no (https://helse norge.no/sykdo m/kreft/ pakke 
forlo p-for-kreft, accessed 1 January 2020). The information is pro-
vided by multiple public health actors, including the Health Library, 
the Directorate of Health, the Norwegian Institute of Public Health 
and the Norwegian Medicines Agency. Additional links to other pa-
tient-focused organizations and to web-based resources for those 
with hearing difficulties are not included in our study. The informa-
tion included a general information and pathways brochures. The 
general information was in Norwegian while the brochures were in 
Norwegian and in English. We used Norwegian text in the corpus 
analysis, however we compared with the English brochures when we 
presented the excerpts in the findings. This study included the gen-
eral information, six specific pathways information and six out of 28 
brochures. Twenty-two brochures were not included because they 
had the same text with different diagnoses and reference to duration 
in terms of weeks and days. The six brochures included in the study 
had different text and dealt with specific, non-specific and meta-
static cancer and pathways specific to women, men and children:
1. Cancer pathways, information to patients. Procedures and tests 
for suspected people with cancer (IS-0469E)
2. Diagnostic cancer pathways, information to patients. Assessment 
of patients with non-specific symptoms of serious illness which 
could be cancer (IS-0478E)
3. Cancer pathways, information for patients. Procedures and tests 
for suspected metastasis of unknown origin (IS-0502E)
4. Procedures and test for suspected cancer in children (IS-0500E)
5. Cancer patways information for patients. Procedures and tests 
for suspected prostate cancer (IS-0467E)
6. Cancer pathways information for patients. Procedures and tests 
for suspected breast cancer (IS-0465E)
We created a small corpus of searchable file of these six TXT 
formatted texts called the Online Cancer Care Pathways Corpus 
(OCCPC) and subjected it to quantitative and qualitative analysis.
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2.4 | Ethical considerations
No formal ethical scrutiny was required or undertaken.
2.5 | Data analysis
We used Corpus Analysis first to establish the quantified ‘linguis-
tic fingerprint’ of the OCCPC (9,464 words) set out above in terms 
of raw frequencies and collocations and then Critical Discourse 
Analysis to describe, interpret and explain the data (Fairclough, 
1992, 2001, 2003) in a three-step process:
2.5.1 | Description of the text
The transcribed interviews were subject to linguistic interpreta-
tion (Fairclough, 2003; Vagle, 2005) by asking the following: Who 
wrote the text and for whom? What authority lies with the pa-
tient? Are patients marked as agentive or passive subjects? What 
kind of evaluative language is used? Are personal pronouns or 
names used? How are modal auxiliary verbs (will, can, should, 
must) used?
2.5.2 | Interpretation of the discursive practice
The themes were interpreted in terms of the relationship between 
the processes of production of the text and the distribution and the 
process of interpretation of the text (Fairclough, 1992, 2001). Then 
interdiscursivity was analysed by examining the particular mix of 
genres and styles of discourses (Fairclough, 2003), i.e. how different 
discourses were expressed in the text.
2.5.3 | Explanation of the social practice
Finally, the discursive practice was explained as a part of the 
contexts of social practice guided by the concept of ideology, 
hegemony and power in Fairclough's theory of discourse. The dis-
cursive practice in the combined corpus of texts is presented in 
the ‘Results’ section and is explained as a social practice in the 
‘Discussion’ section.
2.6 | Rigour
The trustworthiness of the data was secured by describing the docu-
ments and interpretation process thoroughly (Lincoln & Guba, 1985). 
The critical discourse analysis is just one of many readings. It is a cul-
tural production where we bring our preunderstanding of the field 
into the analysis (Rogers & Schaenen, 2014). As registered nurses the 
first and third author brought a preunderstanding of the field to the 
analysed documents, which can be both a strength and a limitation; 
a strength by knowing the field and limitation by the possibility of 
being blind to non-nursing aspects in the texts (Dahl, 2017). The fact 
that the second author does not have an affiliation to the Norwegian 
health system balanced the analysis and results. Sensitive to the po-
sition and resources applied in analysis (Fairclough, 2001), the on-
line cancer pathways documents were read and compared by the 
researchers in an ongoing process and the analysis was supported 
by quotations. Using both quantitative data (computational analysis, 
frequency counts) of several documents and qualitative text analy-
sis, provides a reliable mean of identifying patterns in the documents 
(Crawford et al., 2014).
3  | RESULTS
This study analysed cancer pathways web-based information to pa-
tients in Norway, including the general information and six of 28 spe-
cific pathways. All the 28 brochures of pathways started in the same 
way, beginning in general terms about procedures and tests and then 
assessment phases 1, 2 and 3 with comments and timescales:
You have been referred for assessment by the spe-
cialist health service because there is a suspicion of 
a cancer diagnosis. Specialized procedures and tests 
will determine whether or not you have cancer. If it is 
shown that you do have cancer, your treatment will be 
planned in consultation with you.
The corpus of combined texts about pathways for cancer care, or 
OCCPC, as described above, constructs patients in particular ways in 
relation to their authority through the use of evaluative words, per-
sonal pronouns (instead of names), modal auxiliary verbs (will, can, 
should, must) and active or passive words. In the first instance, we ex-
amined the frequency of words used in the OCCPC (Tables 1 and 2) to 
achieve a broad ‘linguistic signature’ for the combined text to assist a 
critical discourse analysis.
The patients are named as patient/s or referred to the personal 
pronoun forms you and your. The pronoun you is one of the most 
frequent words in the OCCPC and reveals a marked passivity in the 
construction of the patient in the text. All the 28 brochures have the 
same text. For example, the word you is collocated in phrases that 
remove agency, as in ‘you will be given’, ‘you will be told’, ‘you have 
been referred for assessment’, ‘give you more information’. In effect, 
the patients get or receive information. The sentence: ‘Treatment 
will be planned in consultation with you’ is foregrounded at the start 
of each 28-pathway document, however, the word dialogue is only 
mentioned four times in the OCCPC and then in the same general 
information passage. The patient's own perceptions are barely indi-
cated in this text:
The aim is for the patient and relatives to experi-
ence good information, involvement, participation 
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and dialogue … Communication with the patient and 
relatives must be based on respect and empathy. 
Information and dialogue should be done in a consid-
erate manner and be adapted to the recipient's indi-
vidual conditions if, for example, age, social situation 
language, expressed wishes and needs.
Mostly, the OCCPC constructs a passive patient, as further illus-
trated in the frequently occurring word is, with typical phrasing as fol-
lows: and it is decided what treatment you shall get. The power, then, 
belongs to the healthcare system. The dominant discourse is that of 
medical or interprofessional expertise. The word caring or related dis-
course foregrounding caring activity was lacking in the OCCPC. For 
example, the word nursing occurs only five times as connected to the 
concrete cancer disease and treatment. In this way, nursing is limited 
to treatment domains. While this focus may be due to Helsenorge.
no devolving care information through its links to other online cancer 
patient organizations, the discourse of OCCPC from a quantitative per-
spective sets the patient as a passive recipient of expert, disengaged 
intervention.
The analysis of the information to the patients identified three 
core discourses which construct the patient differently:
• Participation discourse
• Medical and interprofessional expert discourse
• Pathways discourse
3.1 | Participation discourse
What any patient might want in the context of care pathways hardly 
features in the OCCPC. For example, the word wish occurs only five 
times. The word need is used only once and then in relation to the 
general need for treatment. Similarly, other words marking involve-
ment of patients remain blatantly low in frequency: participation 
(3), dialogue (4). Reference to patient perceptions or perspectives 
is largely absent. When the OCCPC addresses patient participation, 
this is limited to short paragraphs marked by professional agency 
and direction in any activity as follows:
Furthermore, communication with the patient should 
include clarification regarding expectations about 
the pathway, including the participation of the pa-
tient. Participation and communication provide the 
opportunity to facilitate patient's pathway with good 
continuity.
Based on the pathways, an individual pathway for 
each patient should be organized. In addition to a 
specific medical assessment of the need for assess-
ment and treatment, consideration should be given 
to patients' wishes and individual situation, such 
as age and vulnerability and any comorbidity or 
complications.
3.2 | The medical and interprofessional 
expert discourse
The word ‘we’ is used only five times in the OCCPC and typically de-
scribes the health personnel and the cancer organization: We work 
often interprofessionally. The personal pronoun ‘we’ does not include 
the patient. The words cancer, treatment, assessment, procedure, tests, 
shall and will had a high frequency. As made apparent in the following 
examples, patients are given or told what to do. They are compelled to 
act rather than invited to participate. Patients must do certain things or 
be subject to what the service provider/s has to or have to do:
Information will be given about possible treatments 
and what will happen next. You will be told about the 
procedures and tests that are relevant for you and 
when they will be carried out… You must do prepara-
tion before the test … You must come back to move the 
drain. Sometimes we have to start a treatment – Often 
we have to consider how long and how much. That you 
have another illness that has to be investigated.
The only ground for patient agency was the collocation phys-
ical activity, mentioned 16 times in the OCCPC. For example, we 
Top 50 words used in the OCCPC
1–10 you/your, pathway/s, cancer, shall/will/can, progress, treatment, assessment, 
examination, procedure
11–20 patient/s, test, information, suspicion, been, child, relatives, days, further, 
calendar-days
21–30 may, possible, some, start, time, follow-up, hospital, medical, not, timescale, other, 
phase, finished
31–40 has been, referred, different, national, happened, take, decision/determine, days 
diagnosis, authority
41–52 physically, disease, appointments, based, explained until, give, the current, 
completed, activity, coordinator, doctor
TA B L E  1   Top 50 words used in the 
online cancer care pathways corpus 
(OCCPC)
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read: Many diseases can be prevented and treated with physical ac-
tivity. Often, physical activity can replace drugs or reduce need. But 
even here the word patient is missing and with the subject remain-
ing implicit.
The overall construction of patients as passive as opposed to 
agentive can be seen clearly in the wording of the following example 
from the OCCPC:
Procedures and tests for suspected cancer When 
you attend your first appointment at the hospital, you 
will be told about the procedures and tests that are 
relevant for you and when they will be carried out. 
Various types of procedures and tests are normally 
carried out. During the assessment, your suspected 
cancer will either be confirmed, and you will be given 
TA B L E  2   Sample word frequencies and concordance line for the online cancer care pathways corpus (OCCPC)
Word frequencies and concordance lines.
Totally 9,464 words in the documents
245 Is:
and it is decided what treatment you shall get (all brochures)
the treatment which is best for you (all brochures)
the aim is to speed up patient assessment and start the treatment (all brochures)
176 you:
you can contact the cancer pathway coordinator if you have any question (all brochures)
you will be given a diagnosis (all brochures)
you will be given information on possible treatments (all brochures)
you have been referred for assessment (all brochures)
tests that are planned for you (IS-0469)
168/96 treatment/assessment
to make the assessment period as predictable and stress-free (all brochures)
the treatment that is best for you (IS-0502E)
what treatment you will need (IS-0502E)
141/147 Cancer/pathway/pathways
there will be medical reasons why the cancer pathway should be longer or shorter (all brochures)
the cancer pathway defines the number of calendar days (all brochures)
if you have cancer, your treatment will now be planned (IS-0469)
cancer pathways and pathway timescales are not a legal right (IS-0469)
cancer pathways are intended to give patients and relatives predictability (IS-0467E)
115/114 Will/ be (shall in Norwegian)
medical questions will be answered by a doctor (all brochures)
information also will be given (IS-0502E)
the cancer pathway will be concluded (IS-0467E)
any decision concerning your treatment will be planned in consultation with you (all brochures)
you will be told about the procedures and tests (all brochures)
the cancer pathway coordinator will book the necessary appointments for your procedure (IS-0502E, IS-0467E, IS-0465E)
your doctor will tell you what to expect (IS-0465E)
76 Patient(s)
to give the patient and relatives predictability (all brochures)
cancer patients have their own cancer pathway coordinators (all brochures)
the ideal pathways for most patients. (IS-0469)
patients can sometimes ask to delay their assessment (IS-0469)
56/56 Test/procedures
you will undergo test and procedures (all brochures)
once the procedure and test have been completed, you will be given (IS-0502E)
other procedure and tests may be necessary (IS-0467E, IS-0465E)
7/5 need/ wish
if you need to undergo treatment (IS-0469)
what sort of treatment you will need? (IS-0502E)
the treatment should be considered the patient's wishes and individual situation (general information)
sometimes wish the patient to defer the assessment and treatment (general information)
4/6/1 Participation/communication/dialogue
the goal is that the patient and relatives experience good information, involvement, participation and dialogue with the health service. 
(general information)
participation and communication give possibility for preparer the pathway (general information)
5 Nursing - Only in the general information in the same paragraph.
In cancer pathways, nursing relates to the disease and the treatment of the disease. (general information)
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a diagnosis, or it will be disproven. You may also be re-
ferred for assessment for an illness other than cancer. 
If the assessment indicates that you have cancer, you 
will be given information on possible treatments and 
what will happen next.
In summary, the medical and interprofessional discourse of the 
OCCPC constructs the patient as a person who must listen to and do 
as health professionals decide. The patient is presented as a passive in-
dividual without perceptions and knowledge about their own situation 
and thereby lack power.
3.3 | Pathways discourse
The Norwegian national cancer pathways guidance at Helsenorge.no 
insists that pathways should ideally provide predictability and secu-
rity for the patients and their relatives: The aim is to speed up patient 
assessments and start of treatment and minimize waiting times, to make 
the assessment period as predictable and stress-free as possible for you. 
Perhaps unsurprisingly given the focus, the word pathways have a 
high frequency (147) in the text and the concept is defined in the text 
as follows: The pathways define the number of calendar days that each 
part of the assessment should take. These are called pathway timescales.
That said, this pathways discourse underlines patient passivity. It 
is the hospital's business to ensure the patient completes the path-
way. It is as if the patient is placed on a particular conveyer belt: The 
hospital will do its best to ensure that patients with suspected cancer 
complete their cancer pathway within the time framework described in 
the pathway concerned. This distancing effect, constructing the pa-
tient as a passive recipient in a process not their own, is evident in 
the patient role reduced to asking questions: If you have any ques-
tions, you can contact the cancer pathway contact. This constructed 
passivity is further evident in discourse of the patient as subject to 
program codes, as follows:
The pathways time will be monitored by defined 
codes at different measurement points. Pathways 
prosess start, assessment start/ attendance at the 
spesialist health services, investigation end/decision 
and treatment start. See the code guides.
The patient is effectively constructed as a de-personalized disease 
on care pathways. The patient is granted no agency in timely move-
ment along the pathways. This is the preserve of health professionals 
based on medical reasons why the pathway should be longer or shorter 
than the timescales stated in the national pathway. Furthermore, patients 
are powerless in the face of allocated timelines: The pathways times-
cales are not legally binding. That is, you do not have the right/claim to be 
investigated within the time lapse.
Here, the OCCPC constructs the patient in a very limited way as 
a person who might have something to say in response to the enquiry 
of a health professional. In other words, the scope for participation 
remains in the gift of experts. The patients are constructed as an 
active person in the first paragraph of the information, in each of the 
six documents enfolded into the OCCPC. And then being marked 
as a passive person without perceptions and knowledge about their 
own situation, who has to listen to and do as health professionals 
decide. And finally reduced to a disease and a code that generates 
standardized pathway procedures and timescales (Figure 1).
4  | DISCUSSION
This study analysed the pathways information to patients, estab-
lishing discourses that construct the patient differently (Figure 1), 
represent different ideologies (Fairclough, 1992) or sustain differ-
ent political perspectives. We found that the medical and interpro-
fessional expert discourse and the pathway discourse dominated in 
the care pathways texts, supporting the powerful position of health 
personnel. Røstad et al. (2013) maintain that care pathways have 
mainly been developed by healthcare specialists favouring disease-
based perspectives. Similarly, if we look at the Patient's Rights Act in 
Norway, this is also dominated by the discourse of expertise (Aasen 
& Dahl, 2019). Analysis of other similar legislations in Denmark 
(Lassen et al., 2018) and Sweden (Dahlborg Lyckhage et al., 2017) 
show that the power still belongs to the healthcare system and pro-
motes an ideology of paternalism.
The new cancer strategy in Norway (2018) sets out its ambition 
for a service where patients participate, have an influence on their 
own treatment and get help to manage their illness and everyday life. 
However, the general cancer pathways in Norway have not been up-
dated since 2016 (Health Directorate, 2014), which means that the new 
cancer strategy seems not to have been implemented. The patients are 
offered a standardized cancer pathway (Helse.norge.no, 2020) which is 
intended to reduce unnecessary practice variation, improve coordina-
tion and continuity (Faber et al., 2014) and follow governance systems 
(NPM) in their focus on efficiency and productivity. However, the costs 
have been reduced by implementing standardized pathways (Rotter 
et al., 2010). In the cancer pathways, NPM is visible in the purpose of 
the pathways: ‘to speed up patient assessments and start treatment 
and minimize waiting time, in order to make the assessment period as 
predictable and stress-free as possible for the patient’ (Greve, http://
overl und.dk/samf/NPC.pdf). However, this efficiency and productivity 
might raise questions about the patient's social position and how they 
participate through the stages of the pathway.
The dominant discourse of medical and interprofessional exper-
tise constructs the patient as a passive person positioned to attend to 
what the health professional advises. In an ideology of paternalism, the 
nurse and/or the doctor are supposed to make the period stress-free 
for the patient while leaving little room for patient participation regard-
ing his/her treatment. Similarly, the pathway discourse constructed the 
patient as ‘a diagnosis’ and ‘a code.’ The results of this study are in stark 
contrast to the spirit, tone and requirements of governmental docu-
ments about the cancer strategy (Ministry of Health & Care Services, 
2018), which emphasize active patients, participating in their own 
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treatment. The texts we have examined reveal the recalcitrance of a 
paternalistic ideology despite mandates for patient participation. We 
can see that the standardization of treatment pathways and the dis-
course around these are geared more to the perspectives and power 
of healthcare services and personnel than to the patient requiring care.
4.1 | Standardized pathway timescales versus 
person-centred care
The patients get to know their pathways when they have received a 
diagnosis and then they are allocated a code. This code effectively 
means that the patients have been standardized. All patients with 
the same code get the same timescale. In effect, coding deems pa-
tients as similar rather than unique individuals. Richards et al. (2015) 
(p. 3) argue that person-centredness can only happen if there is a 
person-centred culture and discourse. The cancer pathways did not 
evoke a person-centred culture. The notions of participation and 
dialogical caring practices were mostly absent.
The cancer pathways in the Norwegian information brochures 
start with a short paragraph, constructing the patient as an ac-
tive person in interaction with the health personnel, but this is the 
only time patient participation discourse occurred in these texts. 
Participation ‘does not necessarily require shared decision-mak-
ing but rather a dialogue with shared information and knowledge, 
dialogue and power exchange (Aasen et al., 2012). The dialogue 
and shared knowledge and information are missing in the bro-
chures. What we may call a ‘participation puff’ at the start of the 
information was not extended to the main body and drive of the 
documents.
The information in the brochures said nothing about how to 
meet the ambition of the new cancer strategy in Norway (Ministry 
of Health & Care Services, 2018). The brochures do not mirror 
this strategic vision of a health service where patients participate, 
influence treatment and help patients to manage their own illness 
and everyday life (Ishikawa & Yano, 2008; Street et al., 2009). A 
discourse of caring was not present, with the cancer pathways fo-
cusing only on of the timescales connected to the assessment and 
treatment. There was nothing in these texts about patients hav-
ing agency in seeking help or managing their illness and everyday 
lives. The only sense that patients may be engaged in their own 
care was in the provision of a link to a patient organization and to 
an article of physical activity. As such, we can consider these texts 
as politically situating individual patients in masses or agglomer-
ations, subject to powerful, non-tailored care, losing attention to 
their unique identities, resources and personal needs. In effect, 
the texts of the care pathways are voiding individual patients of 
their personality, hopes and desires. Politically speaking, the ex-
isting, care pathways for cancer care in Norway are proposing pa-
tients as non-autonomous recipients of state help.
4.2 | Limitations
The data we analysed are limited to a Norwegian context and rela-
tively small number of texts. A limited number of documents can 
F I G U R E  1   The process of discourses and constructing the patient in cancer pathways [Colour figure can be viewed at wileyonlinelibrary.
com]
The participation discourse:
The patient is constructed as 
an active person in 
interaction with health 
personnel 
Medical and interprofessional 
expert discourse:
The patient is constructed as 
a passive person without 
knowledge about his/her own 
situation, who has to listen to 
the health professional
Pathwaysdiscourse:
The patient is constructed as 
a disease/diagnosis and a 
code which generates 
standarizied pathway 
timescales
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however be valuable in corpus-assisted discourse analysis (Atkins 
& Harvey, 2010). The results can be deemed transferable to similar 
contexts of care pathways for cancer and possibly for other diagno-
ses in other countries.
5  | CONCLUSION
This study offers insight into the construction of patients in online 
clinical pathways documentation for cancer treatment, with a goal 
to contribute equal and quick investigation and start of treatment 
without unnecessary waiting time (Helse.norge.no, 2020). The analy-
sis of the information on cancer care pathways in the OCCPC and 
its constituent texts revealed how governance systems such as New 
Public Management demands on efficiency and productivity influ-
ence and shape the discourse of cancer pathways. The World Health 
Organization has promoted a person-centred approach where partic-
ipation and a partnership of equals are key. Neither a person-centred 
approach nor caring dialogue was present in the specific pathways. 
The patients are first constructed as participating and active only in 
a very brief participation discourse in the context of a dominant ex-
pert and pathway discourse which reduces patients to ‘a disease’ and 
‘a code’. The dominant ideology of the pathways was found to be 
paternalistic whereby patients were constructed as passive persons 
who get standardized treatment. This can result in a negative impact 
on the patient`s health outcomes in that way that, when the patients 
have received a code and their program for treatment is decided, the 
patients’ needs and wishes are no longer prioritized as important. 
The individual patient joins a coded, standardized group and the care 
pathways texts encourage health practitioners to overlook their pa-
tients’ unique and particular identities and lived experience.
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